Stockreport
Acorda Therapeutics to Present at the Leerink Partners 7th Annual Global Healthcare Conference
Last acorda therapeutics, inc earnings: 2/14 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF
ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Ron Cohen, M.D., Acorda's President and CEO, will present at the Leerink Global Healthcare Conference on Thursday, February 15 at 1:30pm EST. A live audio webcast of the presentation can be accessed under “Investor Events” in the Investor section of the Acorda website at www.acorda.com, or you may use the link: http://wsw.com/webcast/leerink30/acor/ About Acorda Therapeutics Founded in 1995, Acorda Therapeutics is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson’s disease and multiple sclerosis. Acorda markets two FDA-approved therapies, including AMPYRA® (dalfampridine) Extended Release Tab
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | ACOR | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ACOR alerts
ACOR alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACOR alerts
High impacting Acorda Therapeutics, Inc news events
Weekly update
A roundup of the hottest topics
ACOR
NEWS
NEWS
- Acorda Therapeutics Inc (NASDAQ: ACOR) had its "hold" rating re-affirmed by analysts at Oppenheimer Holdings Inc..[MarketBeat]
- Acorda to Present New Long-Term Data for INBRIJA™ (levodopa inhalation powder) at Academy of Managed Care Pharmacy Annual Meeting[Business Wire]
- Acorda Therapeutics Inc (NASDAQ: ACOR) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating.[MarketBeat]
- Acorda Therapeutics chief business officer bids adieu [Seeking Alpha][Seeking Alpha]
- Acorda Therapeutics Announces Management Changes[Business Wire]
- More
ACOR
SEC Filings
SEC Filings
- 3/12/19 - Form 4
- 3/12/19 - Form 4
- 3/12/19 - Form 4
- ACOR's page on the SEC website
- More